Tag: $Dynavax Technologies

Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion

Sanofi (SASY) will buy U.S. vaccines company Dynavax Technologies (DVAX) for around $2.2 billion (1.9 billion euros), the French drugmaker said on Wednesday, a deal that will give it access to an approved hepatitis B vaccine.